We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pregnancy-associated Malaria Vaccine Candidate Passes First Test

News   Jan 11, 2019 | Original story from the University of Copenhagen

 
Pregnancy-associated Malaria Vaccine Candidate Passes First Test

A vaccine against fatal pregnancy malaria shows promising results in the first tests in humans. The new study conducted at the University of Copenhagen has (non-traditionally) taken a vaccine all the way from discovery of a mechanism through development and production to clinical trials in humans. Image credit: University of Copenhagen

 
 
 

RELATED ARTICLES

How Does DEET Keep Mosquitoes at Bay?

News

Since its invention during WWII, researchers have been trying to pinpoint precisely how DEET actually affects mosquitos. New research suggests DEET may chemically “cloak” humans from malaria-carrying mosquitos, rather than repel them.

READ MORE

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

Targeted Therapy Could Help Children With Deadly Nerve Cancer

News

Mount Sinai researchers have discovered a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE